<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Focus (Am Psychiatr Publ)</journal-id>
<journal-id journal-id-type="iso-abbrev">Focus (Am Psychiatr Publ)</journal-id>
<journal-id journal-id-type="pmc">focus</journal-id>
<journal-id journal-id-type="publisher-id">foc</journal-id>
<journal-title-group>
<journal-title>Focus: Journal of Life Long Learning in Psychiatry</journal-title>
</journal-title-group>
<issn pub-type="ppub">1541-4094</issn>
<issn pub-type="epub">1541-4108</issn>
<publisher>
<publisher-name>American Psychiatric Association</publisher-name>
<publisher-loc>Arlington, VA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31975810</article-id>
<article-id pub-id-type="pmc">6526801</article-id>
<article-id pub-id-type="publisher-id">FOC_20160006</article-id>
<article-id pub-id-type="doi">10.1176/appi.focus.20160006</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Clinical Synthesis</subject>
</subj-group>
<subj-group subj-group-type="app-publication-features">
<compound-subject>
<compound-subject-part content-type="code">cm</compound-subject-part>
<compound-subject-part content-type="label">CME</compound-subject-part>
</compound-subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Schizophrenia: An Overview</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Rahman</surname>
<given-names>Tahir</given-names>
</name>
<degrees>M.D.</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lauriello</surname>
<given-names>John</given-names>
</name>
<degrees>M.D.</degrees>
</contrib>
<aff id="aff1">Dr. Rahman is assistant professor of Clinical Psychiatry, University of Missouri—Columbia. Dr. Lauriello is professor and chairman of the Department of Psychiatry and a Robert J. Douglas, M.D., and Betty Douglas Distinguished Faculty Scholar in Psychiatry, University of Missouri—Columbia.</aff>
</contrib-group>
<author-notes>
<corresp id="cor1">Address correspondence to Dr. Rahman (<email xlink:href="rahmantahi@health.missouri.edu">rahmantahi@health.missouri.edu</email>).</corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>7</month>
<year>2016</year>
<string-date>Summer 2016</string-date>
</pub-date>
<pub-date pub-type="epub">
<day>08</day>
<month>7</month>
<year>2016</year>
</pub-date>
<volume>14</volume>
<issue>3</issue>
<issue-title>Schizophrenia: Advances in Understanding and Treatment</issue-title>
<fpage>300</fpage>
<lpage>307</lpage>
<permissions>
<copyright-statement>Copyright © by the American Psychiatric Association</copyright-statement>
<copyright-year>2016</copyright-year>
</permissions>
<self-uri content-type="pdf" xlink:href="appi.focus.20160006.pdf" xlink:title="pdf"></self-uri>
<abstract>
<p>Few changes were made to the diagnostic criteria for schizophrenia in <italic>DSM-5</italic>. Schizophrenia is a chronic mental illness with positive symptoms (delusions, hallucinations, disorganized speech and behavior), negative symptoms, and cognitive impairment. Discoveries in genetics, neuroimaging, and immune function continue to advance understanding of the etiologies for this elusive disease. The authors reviewed the current literature to give an overview. The topics include historical foundations, epidemiology, suicide risk, genomewide association studies, twin studies, neuroimaging, ventricular size, complement component 4 mediated synapse elimination, major histocompatibility complex markers, and associations seen in obstetrical complications, nutritional issues, prodromal and attenuated states, cannabis use, childhood trauma, immigration, and traumatic brain injury. Also reviewed are expressed emotions of caregivers and recidivism, conditions comorbid with obsessive-compulsive disorder, mood disorders, substance use, and finally some legal and ethical issues. These important developments in elucidating the disease mechanism will likely allow for the development of future novel treatment strategies.</p>
</abstract>
<counts>
<fig-count count="0"></fig-count>
<table-count count="0"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="69"></ref-count>
<page-count count="8"></page-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name> DJS Export </meta-name>
<meta-value>v1</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
</article>
</pmc-articleset>